Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Acta Pharmaceutica Sinica B
>
2016
>
6
>
5
Volume:
6
Issue:
5
1. PBPK modeling and simulation in drug research and development.
Page:430—440
2. Editorial of Virtual Special Issue on Progress in Medicinal Chemistry.
Page:510—511
3. 17-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expressionestrogen receptor.
Page:504—509
4. Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.
Page:492—503
5. Characterizing drug-metabolizing enzymes and transporters that areCAR-target genes in mouse intestine.
Page:475—491
6. Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administration.
Page:468—474
7. Tissue distribution and tumor uptake of folate receptor-targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration.
Page:460—467
8. Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver.
Page:453—459
9. A brief history of the discovery of PXR and CAR as xenobiotic receptors.
Page:450—452
10. variants: the impact on drug metabolism and therapeutic responses.
Page:441—449
11. Exposure to inorganic arsenic can lead to gut microbe perturbations and hepatocellular carcinoma.
Page:426—429
12. Insights into CYP2B6-mediated drug-drug interactions.
Page:413—425
13. Fatty liver diseases, bile acids, and FXR.
Page:409—412
14. Crosstalk of HNF4with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids.
Page:393—408
15. Isoniazid metabolism and hepatotoxicity.
Page:384—392
16. An update on the role of intestinal cytochrome P450 enzymes in drug disposition.
Page:374—383
17. Renal drug transporters and their significance in drug-drug interactions.
Page:363—373
18. Advanced knowledge in drug metabolism and pharmacokinetics.
Page:361—362
19. Editor Profiles: Guest Editors of Special Issue on Drug Metabolism and Pharmacokinetics.
Page:359—360